Tomorrow we will present at #NeuroFrance2025 our results using #CAV-2 vectors in the #cerebellum

Today we presented our SCN1A-mCitrine mouse to help to study the bio distribution of #Nav1.1 #NeuroFrance2025. This will help to understand #DravetSyndrome #Montpellier if you are interested to use it just contact us

Los #venenos que esconden una cura... Fármacos para la hipertensión, obesidad o cáncer desarrollados a partir de venenos de arañas, lagartos y serpientes. El increíble poder de las toxinas que revoluciona la #medicina Muy interesante 👇🏻👇🏻👇🏻 www.lavozdegalicia.es/xlsemanal/ci...

#YIYmeeting2024 #Coruña Muy bien recibidos en el #Domus iyimeeting.com/programa/

#IYImeeting2004 presentando nuestro trabajo #Dravet Retos y posibilidades de la terapia génica en el tratamiento de Dravet #terapiagenica

#microglia #alzheimer #darkmicrohlia Descubierto el mecanismo de la “microglía oscura”, una posible causa del alzhéimer. Integrated Stress Response Associated with Dark Microglia Contributes to Neurodegeneration. papers.ssrn.com/sol3/papers....

#ExpertsCNRS Journalistes, à l’approche de l’hiver, le service presse du CNRS vous propose des scientifiques spécialistes des énergies pour vous éclairer sur le sujet.❄️ 👉 www.cnrs.fr/fr/presse/li...

Explore "Expert Perspectives on Dravet Syndrome Management" with Dr. Scott Perry (@thenotoriouseeg.bsky.social), covering diagnosis, emerging therapies, and care strategies. Gain valuable insights here: bit.ly/4fHiMab #DSF #DravetSyndrome

JUST PUBLISHED! Cambridge "SCN2A-Related Disorders" Written and edited by leading experts, this comprehensive review explores the clinical spectrum, genetics, and therapeutic advances surrounding SCN2A-related conditions. Open access made possible by FamilieSCN2A. www.scn2a.org/pdf/scn2arel...